2016-04-07 |
102 |
|
Initial Invalidity Contentions for U.S. Patent No. 9,259,428 Pursuant to the Courts Default Standard … 2 December 2014
1:14-cv-01453-LPS
Patent
None
District Court, D. Delaware |
External link to document |
2016-05-12 |
114 |
|
.S. Patent Nos. 8,163,723 (the "' 723 patent"), 8,168,620 (the "'620 patent"…),
and 9,259,428 (the '"428 patent"). The patents are directed to a single-dosage formulation…; It is a bedrock principle of patent law that the
claims of a patent define the invention to which the…reading the entire patent." Id. at 1321
(internal quotation marks omitted). The patent specification …28 of the ' 723 patent and claims 16,
17, and 24 of the of the ' 620 patent.
3
|
External link to document |
2016-12-12 |
148 |
|
Prejudice of all Claims Concerning U.S. Patent No. 8,163,723 by Cipla Ltd., Meda Pharmaceuticals Inc.… 2 December 2014
1:14-cv-01453-LPS
Patent
None
District Court, D. Delaware |
External link to document |
2015-07-13 |
30 |
|
Initial Infringement Contentions for U.S. Patent Nos. 8,163,723 and 8,168,620 filed by Cipla Ltd., Meda … 2 December 2014
1:14-cv-01453-LPS
Patent
None
District Court, D. Delaware |
External link to document |
2014-12-02 |
4 |
|
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,163,723; 8,168,620;. (els) … 2 December 2014
1:14-cv-01453-LPS
Patent
None
District Court, D. Delaware |
External link to document |
2016-03-01 |
92 |
|
Initial Infringement Contentions for U.S. Patent No. 9,259,428 filed by Cipla Ltd., Meda Pharmaceuticals… 2 December 2014
1:14-cv-01453-LPS
Patent
None
District Court, D. Delaware |
External link to document |